关注
Giovanni Germano
Giovanni Germano
未知所在单位机构
在 unito.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
G Solinas, G Germano, A Mantovani, P Allavena
Journal of leukocyte biology 86 (5), 1065-1073, 2009
17402009
Role of macrophage targeting in the antitumor activity of trabectedin
G Germano, R Frapolli, C Belgiovine, A Anselmo, S Pesce, M Liguori, ...
Cancer cell 23 (2), 249-262, 2013
8902013
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
G Germano, S Lamba, G Rospo, L Barault, A Magrì, F Maione, M Russo, ...
Nature 552 (7683), 116-120, 2017
5452017
Cytokines as a key component of cancer-related inflammation
G Germano, P Allavena, A Mantovani
Cytokine 43 (3), 374-379, 2008
4002008
Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells
G Germano, R Frapolli, M Simone, M Tavecchio, E Erba, S Pesce, ...
Cancer research 70 (6), 2235-2244, 2010
2982010
SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo
S Mainardi, A Mulero-Sánchez, A Prahallad, G Germano, A Bosma, ...
Nature medicine 24 (7), 961-967, 2018
2922018
Chemokines in cancer related inflammation
P Allavena, G Germano, F Marchesi, A Mantovani
Experimental cell research 317 (5), 664-673, 2011
2852011
Cancer‐promoting tumor‐associated macrophages: New vistas and open questions
A Mantovani, G Germano, F Marchesi, M Locatelli, SK Biswas
European journal of immunology 41 (9), 2522-2525, 2011
2472011
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
BO Van Emburgh, S Arena, G Siravegna, L Lazzari, G Crisafulli, G Corti, ...
Nature communications 7 (1), 13665, 2016
2012016
PTPN11 is a central node in intrinsic and acquired resistance to targeted cancer drugs
A Prahallad, GJJE Heynen, G Germano, SM Willems, B Evers, ...
Cell reports 12 (12), 1978-1985, 2015
1802015
High-dose vitamin C enhances cancer immunotherapy
A Magrì, G Germano, A Lorenzato, S Lamba, R Chilà, M Montone, ...
Science translational medicine 12 (532), eaay8707, 2020
1602020
Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma
M Liguori, G Solinas, G Germano, A Mantovani, P Allavena
Cancers 3 (4), 3740-3761, 2011
952011
The clinical impact of the genomic landscape of mismatch repair–deficient cancers
G Germano, N Amirouchene-Angelozzi, G Rospo, A Bardelli
Cancer discovery 8 (12), 1518-1528, 2018
872018
RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas
E Fagiani, G Giardina, L Luzi, M Cesaroni, M Quarto, M Capra, ...
Cancer research 67 (7), 3064-3073, 2007
872007
Trabectedin: A drug from the sea that strikes tumor-associated macrophages
P Allavena, G Germano, C Belgiovine, M D’Incalci, A Mantovani
Oncoimmunology 2 (6), e24614, 2013
672013
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients
G Crisafulli, A Sartore-Bianchi, L Lazzari, F Pietrantonio, A Amatu, ...
Cancer Discovery 12 (7), 1656-1675, 2022
522022
Parallel evaluation of circulating tumor DNA and circulating tumor cells in metastatic colorectal cancer
G Germano, G Mauri, G Siravegna, C Dive, J Pierce, F Di Nicolantonio, ...
Clinical Colorectal Cancer 17 (1), 80-83, 2018
472018
CD4 T cell–dependent rejection of beta-2 microglobulin null mismatch repair–deficient tumors
G Germano, S Lu, G Rospo, S Lamba, B Rousseau, S Fanelli, D Stenech, ...
Cancer discovery 11 (7), 1844-1859, 2021
432021
Evolving neoantigen profiles in colorectal cancers with DNA repair defects
G Rospo, A Lorenzato, N Amirouchene-Angelozzi, A Magrì, C Cancelliere, ...
Genome medicine 11, 1-22, 2019
422019
Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers
V Amodio, G Mauri, NM Reilly, A Sartore-Bianchi, S Siena, A Bardelli, ...
Cancers 13 (11), 2638, 2021
402021
系统目前无法执行此操作,请稍后再试。
文章 1–20